Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
0 Saves · 0 Shares · 1 Comments Discussion
Related opportunities
- Northern Territory Pathways to Community Control
- Indigenous Health 30-Jun-2024 $8,750,000.00
- Leading Engineering for America's Prosperity, Health, and Infrastructure
- Science and Technology and other Researc... Sep 16, 2024 12:00:00 AM EDT $2,000,000
- Tribal Behavioral Health
- Health May 15, 2025 12:00:00 AM EDT $250,000
- Strategic Prevention Framework – Partnerships for Success for States
- Health Jun 05, 2025 12:00:00 AM EDT $1,250,000
- Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed)
- Health Jun 06, 2025 12:00:00 AM EDT $295,924
- Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) Clinical Trial Not Allowed
- Health Jun 06, 2025 12:00:00 AM EDT $295,924
- Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
- Health Sep 05, 2025 12:00:00 AM EDT $1,838,436